KRISTINA SKARBINSKI: Open Payments
NPI 1124459623 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,979 in 25 payments from 7 companies in 2025. Trend: 2023 $1,853 · 2024 $8,262 · 2025 $11,979
Consulting: $9,932Food & beverage: $1,311Speaker / faculty: $500Travel & lodging: $236
| Company | Payments | Amount |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC | 7 | $8,789 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $1,749 |
| Ardelyx, Inc. | 3 | $701 |
| Phathom Pharmaceuticals, Inc. | 5 | $408 |
| GENZYME CORPORATION | 2 | $240 |
| Ferring Pharmaceuticals Inc. | 1 | $62 |
| ABBVIE INC. | 1 | $31 |
Products named: TRULANCE, IBSRELA, VOQUEZNA, DUPIXENT, LINZESS, REBYOTA, XIFAXAN.
Industry payments across MA — which companies pay providers there.
